Vice PresidentSciLucent, Inc.San Diego, California, United States
Regulatory Toxicology Case Studies: An Interactive Session Involving Industry, CRO, Consultant and Regulatory Perspectives (CE1)
Sunday, November 17, 20248:00 AM - 11:30 AM CT
Case Study Example #2: Leveraging the 505(b)(2) Pathway for an Investigational New Drug Formulation Using New Administration Modalities (CE1-3)
Sunday, November 17, 20248:50 AM - 9:30 AM CT